Editor's Review

According to the study, the most common mental health problems reported by recovered Covid-19 patients include; anxiety, depression and insomnia. 

A new study has revealed a worrying trend where one out of five recovered Covid-19 patients are contracting mental illness within 90 days.

According to the study, the most common mental health problems reported by recovered Covid-19 patients include; anxiety, depression, and insomnia.

“People have been worried that Covid-19 survivors will be at greater risk of mental health problems, and our findings … show this to be likely,” Paul Harrison, a professor of psychiatry at Britain’s Oxford University said as quoted by Citizen.

The study further established that persons with pre-existing mental illness stand a higher chance of contracting the virus than those without pre-conditions.

Locally, the number of Covid-19 infections has been on the rise with hundreds of new cases being reported on a daily basis.

Read More

  1. MoH Condemns Insurance Company Issuing Cover for 'Adverse Effects of Covid-19 Vaccine'
  2. Gov’t Gives Civil Servants 2 Weeks to Get Covid-19 Jab or Face Disciplinary Action
  3. Raila Shares his 5-Point Plan on How to Improve Kenya’s Ailing Health Sector

Progress on Covid-19 Vaccine


Meanwhile, researchers are on course to develop a vaccine for the virus.

On Monday, Pfizer Inc. Chief Executive Officer Albert Bourla stated that early efficacy tests of its coronavirus vaccine show that it's 90 percent effective.

Bourla further noted that the pharmaceutical company and its collaborator BioNTech found in a phase 3 study that the potential COVID-19 vaccine was "found to be more than 90 percent effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis."

"The results demonstrate that our mRNA-based vaccine can help prevent COVID-19 in the majority of people who receive it," said Bourla. "This means we are one step closer to potentially providing people around the world with a much-needed breakthrough to help bring an end to this global pandemic," Bourla said.